Vimpat Tolerability
Links shared publicly online about this topic
Vimpat (lacosamide) provided sustained efficacy and good tolerability for up to 8 years in patients with partial onset seizures - Drugs.com MedNews
drugs.com — “Long term data from four open label lacosamide extension trials reported at the 29th International Epilepsy Congress New non-interventional study (VITOBA ) aims” View full resource at drugs.com
Most Recently Shared on September 1, 2011 at 10:01 pm By:
Drugs and Devices OW OW Health
Vimpat (lacosamide) provided sustained efficacy and good tolerability for up to 8 years in patients with p... http://t.co/oazh0jZ #drug
UCB Media Centre - Vimpat® (lacosamide) provided sustained efficacy and good tolerability for up to 8 years in patients with partial onset seizures
ucb.presscentre.com — “For the attention of accredited medical writers only• Long term data from four open label lacosamide extension trials reported at the 29th International Epilepsy Congress • New non-interventional study (VITOBA™) aims to investigate additive or synergistic effects of lacosamide with single antiepileptic drug (AED) treatment” View full resource at ucb.presscentre.com
Most Recently Shared on August 31, 2011 at 12:24 pm By:
Actually the UCB/Vimpat link is this: http://t.co/Sgp6Aff
Vimpat® (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless Of The Mechanism Of Action Of Concomitant Antiepileptic Drugs
medicalnewstoday.com — “Comprehensive analyses of pooled data from three randomized, double-blind, placebo-controlled Phase II/III trials showing the efficacy and tolerability of Vimpat® (lacosamide) C-V for patients” View full resource at medicalnewstoday.com
Most Recently Shared on January 13, 2011 at 3:05 pm By:
MNT Pharma News Health News and Pharma
Vimpat® (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless Of The Mechanism Of Action Of Concomi... http://mnt.to/3PXs
Vimpat (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless of the Mechanism of Action of Concomitant Antiepileptic Drugs - Drugs.com MedNews
drugs.com — “Comprehensive lacosamide analyses published in CNS Drugs - Pooled phase II III clinical trial data demonstrated efficacy and tolerability of lacosamide as adjun” View full resource at drugs.com
Most Recently Shared on January 12, 2011 at 7:18 pm By:
Drugs and Devices OW OW Health
Vimpat (lacosamide) Significantly Reduced Partial-Onset Seizures Regardless of the Mechanism of Action of ... http://bit.ly/dQh82u #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
FiercePharma
FiercePharma's 140. Join 50,000 pharma insiders on our free newsletter at FiercePharma.com
-
MNT Pharma News
The latest pharma industry news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
